Northern California Retina Vitreous Associates   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: CA United States (1983)

Organization Overview

First Clinical Trial
2011
NCT01284478
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now